Article
The increasing application of multiplex nucleic acid detection tests to the diagnosis of syndromic infections
7 Oct 2013
Abstract excerpt
On 14 January 2013, the US Food and Drug Administration (FDA) announced permission for a multiplex nucleic acid test, the xTAG® Gastrointestinal Pathogen Panel (GPP) (Luminex Corporation, USA), which simultaneously detects 11 common viral, bacterial and parasitic causes of infectious gastroenteritis, to be marketed in the USA. This announcement reflects the current move towards the development and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
